Generic Drug Makers Did Not Violate Antitrust Law: Jury

Law360, New York (April 7, 2006, 12:00 AM EDT) -- Ending a long-running antitrust dispute that went all the way to the Federal Circuit and back, a California jury has ruled that generic drug maker Sandoz Inc. did not violate antitrust laws when it refrained from marketing a generic hypertension drug.

The drawn-out multi-jurisdictional litigation began in 1998, when Kaiser Foundation Health Plan Inc. sued Sandoz predecessor Geneva Pharmaceuticals Inc. and generic drug maker Abbott Laboratories over their agreement to halt marketing of the drug while patent litigation between the companies was pending.

The jury decided...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.